Prime Medicine, Inc. (PRME)
3.315
-0.30
(-8.17%)
USD |
NASDAQ |
Oct 13, 16:00
3.315
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine EPS Diluted (TTM) : -1.086 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.086 |
| March 31, 2026 | -1.255 |
| December 31, 2025 | -1.374 |
| September 30, 2025 | -1.475 |
| June 30, 2025 | -1.599 |
| March 31, 2025 | -1.656 |
| December 31, 2024 | -1.697 |
| September 30, 2024 | -2.015 |
| June 30, 2024 | -2.128 |
| March 31, 2024 | -2.133 |
| December 31, 2023 | -2.137 |
| September 30, 2023 | -1.880 |
| Date | Value |
|---|---|
| June 30, 2023 | -1.696 |
| March 31, 2023 | -1.600 |
| December 31, 2022 | -1.471 |
| September 30, 2022 | -1.777 |
| June 30, 2022 | -1.648 |
| March 31, 2022 | -1.320 |
| December 31, 2021 | -1.923 |
| September 30, 2021 | -1.235 |
| June 30, 2021 | -0.9967 |
| March 31, 2021 | -0.9527 |
| December 31, 2020 | -0.035 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Beam Therapeutics, Inc. | -0.86 |
| Twist Bioscience Corp. | -2.224 |
| Intellia Therapeutics, Inc. | -3.357 |
| Moderna, Inc. | -7.985 |
| Q32 Bio, Inc. | 3.001 |